


Illumind Therapeutics
Biotechnology Research • 1460 Rue de l'église, Montreal, Canada • 1-10 Employees
Company overview
| Headquarters | 1460 Rue de l'église, Montreal, Quebec H4L 2J8, CA |
| Website | |
| NAICS | 541714 |
| Keywords | Mental Health, Biotech, Ptsd |
| Founded | 2025 |
| Employees | 1-10 |
Key Contact at Illumind Therapeutics
Christelle Bitar
Co-founder
About Illumind Therapeutics
Illumind Therapeutics is a Quebec-based neuroscience company developing new approaches to better understand and treat post-traumatic stress. Building on more than a decade of research, it is now initiating clinical studies based on an innovative scientific model of mental illness. Illumind Therapeutics collaborates with strategic partners committed to advancing current standards in mental health.
Illumind Therapeutics revenue & valuation
| Annual revenue | $171,110 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $547,552 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Illumind Therapeutics has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Illumind Therapeutics has never raised funding before.
Frequently asked questions
4.8
40,000 users



